Cargando…
Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia
BACKGROUND: A typical antipsychotics for neuropsychiatric symptoms in dementia have been tested in much larger trials than the older conventional drugs. The advantage of larger sample sizes is that negative findings become less likely and the effect estimates more precise. However, as sample sizes i...
Autores principales: | Hulshof, Tessa A., Zuidema, Sytse U., Janus, Sarah I. M., Luijendijk, Hendrika J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047221/ https://www.ncbi.nlm.nih.gov/pubmed/32153391 http://dx.doi.org/10.3389/fphar.2019.01701 |
Ejemplares similares
-
Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia
por: Vredeveld, Eline J., et al.
Publicado: (2019) -
Run‐in periods and clinical outcomes of antipsychotics in dementia: A meta‐epidemiological study of placebo‐controlled trials
por: Hulshof, Tessa A., et al.
Publicado: (2019) -
Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials
por: Hulshof, Tessa A., et al.
Publicado: (2018) -
Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006) -
Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia
por: Ng, Kok Pin, et al.
Publicado: (2019)